? This project describes a biochemical engineering approach to design a process and platform for the de novo synthesis of large DNA molecules from precursor synthetic 5'OH oligonucleotides, 30-40 nucleotides long. The instrument is engineered with two applications in mind: (1) assembly of genes from synthetic oligonucleotides and (2) site-directed mutagenesis. The unique features of the technology are the speed of assembly and the low error frequencies of products. The overall objective (end of R33) is to develop an instrument that interacts with users by keyboard and performs the following biochemical steps automatically: (1) Polymerase chain assembly (PCA) of 1,000-2,000 base pairs (bp) double-stranded DNA fragments in each of two cuvettes in less than thirty minutes and with an accuracy of less than one error/1,000 bp. (2) Immunocapture of the 5BrU and 6mA hapten-labeled DNA fragments. (3) Treat the DNA fragments with T4 polymerase. In the absence of dNTP's, the 3' exonuclease activity of the T4 polymerase removes 20-30 nucleotides from the 3' ends of the DNA fragments. (4) Join the two DNA fragments, which contain 5' single stranded ends, following a ligase-independent cloning strategy. The deliverable at the end of the R21 phase would be a prototype that performs the first two steps. The de novo gene assembly technology proposed here allows genes to be synthesized on a time scale of a few hours once important proteins are identified. The synthetic genes can be cloned and overexpressed to provide a large quantity of pure protein. Purified proteins may be used to generate high-affinity reagents that can be employed in protein arrays. The development of protein arrays will provide a quick and efficient procedure to assay the expression and regulation of the protein under investigation and of other proteins involved in toxic-response. The combination of rapid automated gene synthesis with proteomics may accelerate the development of new disease markers and drug targets. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21RR022860-01
Application #
7088233
Study Section
Special Emphasis Panel (ZRR1-BT-6 (01))
Program Officer
Farber, Gregory K
Project Start
2006-09-15
Project End
2011-08-31
Budget Start
2006-09-15
Budget End
2007-08-31
Support Year
1
Fiscal Year
2006
Total Cost
$180,974
Indirect Cost
Name
University of Nebraska Lincoln
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
555456995
City
Lincoln
State
NE
Country
United States
Zip Code
68588
Louw, Tobias M; Booth, Christine S; Pienaar, Elsje et al. (2011) Experimental Validation of a Fundamental Model for PCR Efficiency. Chem Eng Sci 66:1783-1789
Booth, Christine S; Pienaar, Elsje; Termaat, Joel R et al. (2010) Efficiency of the Polymerase Chain Reaction. Chem Eng Sci 65:4996-5006
TerMaat, Joel R; Mamedov, Tarlan G; Pienaar, Elsje et al. (2010) Automated two-column purification of iminobiotin and BrdU-labeled PCR products for rapid cloning: application to genes synthesized by polymerase chain assembly. J Chromatogr Sci 48:120-4
Mamedov, T G; Pienaar, E; Whitney, S E et al. (2008) A fundamental study of the PCR amplification of GC-rich DNA templates. Comput Biol Chem 32:452-7
Pienaar, Elsje; Viljoen, Hendrik J (2008) The tri-frame model. J Theor Biol 251:616-27
Fluitt, Aaron; Pienaar, Elsje; Viljoen, Hendrik (2007) Ribosome kinetics and aa-tRNA competition determine rate and fidelity of peptide synthesis. Comput Biol Chem 31:335-46
Mamedov, Tarlan G; Padhye, Nisha V; Viljoen, Hendrik et al. (2007) Rational de novo gene synthesis by rapid polymerase chain assembly (PCA) and expression of endothelial protein-C and thrombin receptor genes. J Biotechnol 131:379-87